Clinical trial
Study of Weekly Radiotherapy for Bladder Cancer (HYBRID)
In patients with muscle invasive bladder cancer not suitable for cystectomy or daily radiotherapy we aim to assess:
- whether treatment using adaptive planning can be successfully delivered at multiple sites across the UK and results in acceptable levels of toxicity
- the local tumour control rate achieved by hypofractionated weekly radiotherapy
- the requirement to treat with adaptive planning.
Category | Value |
---|---|
Study start date | 2013-03-08 |